PT Pyridam Farma Tbk
PYFA
Rank in Stocks
#20981
PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the... PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the development, production, and distribution of a broad spectrum of health-related products. Its offerings encompass pharmaceuticals, antibiotics, essential vitamins, dietary supplements, and traditional herbal remedies. The company's operations are divided into two main segments: Pharmaceutical Products and Contract Manufacturing Services, and Medical Device Products. Within its medical device division, the firm provides a variety of instruments and consumables. These include clinical waste management items, collection swabs and tubes, innerbox DCA, KF94 masks, parafilm, PCR extraction kits and their accompanying machinery, specimen bags, sterile containers, and tube stoppers. Furthermore, PT Pyridam Farma markets a diverse collection of skincare products, such as Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel. Its pharmaceutical portfolio addresses numerous therapeutic areas, including digestive and metabolic health, blood and blood-forming organ conditions, cardiovascular disorders, dermatological ailments, genitourinary system and sex hormone regulation, systemic corticosteroids, systemic antibacterial treatments, sensory organ issues, as well as musculoskeletal, nervous, and respiratory system conditions. Beyond medicinal lines, the company also develops and sells dietary supplements and preventive consumer health items, notably energy drinks and various healthy ready-to-consume beverages. A key area of its strategic focus involves conducting extensive research and development in biotechnology, life sciences, and medical science. Established in 1976, PT Pyridam Farma Tbk is headquartered in Jakarta, Indonesia.
Share Price
$0.00670277
Last synced: 2026-11-10
Market Cap
$75.32M
Change (1 day)
2.54%
Change (1 year)
-79.60%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Pyridam Farma Tbk (PYFA)
Category
Healthcare
Earnings for PT Pyridam Farma Tbk (PYFA)
Earnings in Jun 2026 TTM: $-26.86M
According to PT Pyridam Farma Tbk's latest financial reports, its current earnings (TTM) are $-26.86M. In 2025 the company earned $-31.80M, a decrease compared to its 2024 earnings of $-19.31M. The earnings shown on this page are earnings before interest and taxes, or EBIT.
Earnings history for PT Pyridam Farma Tbk from 2005 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $-26.86M | -15.53% |
| 2025 | $-31.80M | 64.72% |
| 2024 | $-19.31M | 256.90% |
| 2023 | $-5.41M | -131.95% |
| 2022 | $16.93M | 2,636.58% |
| 2021 | $618.69K | -70.87% |
| 2020 | $2.12M | 135.71% |
| 2019 | $901.06K | 15.21% |
| 2018 | $782.12K | 10.51% |
| 2017 | $707.75K | 35.16% |
| 2016 | $523.64K | 58.74% |
| 2015 | $329.87K | -2.71% |
| 2014 | $339.07K | -51.42% |
| 2013 | $697.89K | -15.56% |
| 2012 | $826.52K | 5.78% |
| 2011 | $781.33K | 24.58% |
| 2010 | $627.19K | 8.92% |
| 2009 | $575.82K | 74.07% |
| 2008 | $330.80K | 18.52% |
| 2007 | $279.11K | -10.60% |
| 2006 | $312.21K | 57.58% |
| 2005 | $198.13K | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $3.59B | -13,473.83% |
DE
|
|
| $3.38B | -12,686.89% |
DE
|
|
| $2.53B | -9,531.86% |
JP
|
|
| $930.30M | -3,563.18% |
CH
|
|
| $381.32M | -1,519.50% |
IL
|
Questions about PT Pyridam Farma Tbk's net income
What is PT Pyridam Farma Tbk's net income?
PT Pyridam Farma Tbk's net income over the last twelve months is $-26.86M, as of Jun 2026.
What was PT Pyridam Farma Tbk's net income in 2025?
In 2025, PT Pyridam Farma Tbk's net income was $-31.80M, compared with $-19.31M in 2024.
How has PT Pyridam Farma Tbk's net income changed since 2020?
From 2020 to 2025, PT Pyridam Farma Tbk's net income was highest in 2022 ($16.93M) and lowest in 2025 ($-31.80M).
How does PT Pyridam Farma Tbk's net income compare with similar companies?
PT Pyridam Farma Tbk's net income ($-26.86M) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $3.59B.